Compounds > tipifarnib
Page last updated: 2024-09-04

tipifarnib and wortmannin

tipifarnib has been researched along with wortmannin in 1 studies

Compound Research Comparison

Studies
(tipifarnib)		Trials
(tipifarnib)		Recent Studies (post-2010)
(tipifarnib)		Studies
(wortmannin)		Trials
(wortmannin)		Recent Studies (post-2010) (wortmannin)
30992944,0662726

Protein Interaction Comparison

ProteinTaxonomytipifarnib (IC50)wortmannin (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0465
Myosin light chain kinase, smooth muscleGallus gallus (chicken)0.26
Metabotropic glutamate receptor 1Rattus norvegicus (Norway rat)0.0085
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.2368
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.1309
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0493
Serine/threonine-protein kinase mTORHomo sapiens (human)0.04
Phosphatidylinositol 4-kinase alphaHomo sapiens (human)0.28
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.0492
Serine/threonine-protein kinase PLK1Homo sapiens (human)0.4433
Myosin light chain kinase, smooth muscleHomo sapiens (human)2.3567
Phosphoinositide 3-kinase regulatory subunit 5Homo sapiens (human)0.019
Serine/threonine-protein kinase PLK3Homo sapiens (human)0.1057
Phosphatidylinositol 4-kinase betaHomo sapiens (human)0.44

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babic, T; Buric, SS; Dinic, J; Hadzic, S; Pesic, M; Radojkovic, D; Rankov, AD1

Other Studies

1 other study(ies) available for tipifarnib and wortmannin

ArticleYear
Comparative toxicity evaluation of targeted anticancer therapeutics in embryonic zebrafish and sea urchin models.
    Acta biologica Hungarica, 2018, Volume: 69, Issue:4

    Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Arbacia; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Embryonic Development; Enzyme Inhibitors; Molecular Targeted Therapy; Morpholines; Oxadiazoles; Pyrimidines; Quinolones; Signal Transduction; Wortmannin; Zebrafish

2018